Citation Impact
Citing Papers
Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination
2004
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: A pilot study
2005
Treating hepatitis C infection in liver transplant recipients
2006
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
2006
Early Hepatic Stellate Cell Activation Predicts Severe Hepatitis C Recurrence after Liver Transplantation
2005
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus
2007
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
2007
Impact of Donor Age and Year of Transplantation on Graft and Patient Survival Following Liver Transplantation for Hepatitis C Virus
2006
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
2004
Budd–Chiari syndrome: a review by an expert panel
2003
The impact of disease recurrence on graft survival following liver transplantation: a single centre experience
2008
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
2005 Standout
Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome
2001
Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment
2006
TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience
2003
The Impact of IL28B Genetic Variants on Recurrent Hepatitis C in Liver Transplantation: Significant Lessons from a Dual Graft Case
2011
Antithrombotic Therapy for VTE Disease
2016 Standout
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
2006
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
The prognostic value of histology in the assessment of patients with Budd–Chiari syndrome
2001
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
2004
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression
2006
Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature
2003
Vascular disorders of the liver # †
2008 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
The natural history of recurrent hepatitis C and what influences this
2008
Treatment of Budd‐Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto‐systemic shunt and liver transplantation
2004
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Procedimientos radiológicos intervencionistas, angioplastia y DPPI en el tratamiento del síndrome de Budd-Chiari
2003
Percutaneous balloon angioplasty of inferior vena cava in Budd–Chiari syndrome-R1
2002
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome
2003
Liver transplantation for budd-chiari syndrome
2002
The utility of radiological imaging in nonalcoholic fatty liver disease
2002 Standout
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
2012 Standout
Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome
2005
The role of liver biopsy in chronic hepatitis C
2002
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Graft histology characteristics in long-term survivors of pediatric liver transplantation
2008
Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
2006
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt
2004
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Progression of fibrosis in advanced chronic hepatitis C
2007
Natural History of Hepatitis C
2005
Multi-State Models for Panel Data: ThemsmPackage forR
2011 Standout
The role of liver biopsy in chronic hepatitis C
2002
Liver Transplantation for Malignancy
2005
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Works of M Wali being referenced
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C
2002
Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting
1999
Histological progression during short‐term follow‐up of patients with chronic hepatitis C virus infection
1999
Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4
2003